Assessing Healthspan in Long Lived C. elegans by Beverly, Lindsey
University of Colorado, Boulder
CU Scholar
Undergraduate Honors Theses Honors Program
Spring 2013
Assessing Healthspan in Long Lived C. elegans
Lindsey Beverly
University of Colorado Boulder
Follow this and additional works at: http://scholar.colorado.edu/honr_theses
This Thesis is brought to you for free and open access by Honors Program at CU Scholar. It has been accepted for inclusion in Undergraduate Honors
Theses by an authorized administrator of CU Scholar. For more information, please contact cuscholaradmin@colorado.edu.
Recommended Citation
Beverly, Lindsey, "Assessing Healthspan in Long Lived C. elegans" (2013). Undergraduate Honors Theses. Paper 398.
MARCH 31, 2013 
Assessing Healthspan in Long Lived C. elegans 
Lindsey Beverly 
 
Undergraduate thesis submitted to the Department of Integrative 
Physiology, University of Colorado at Boulder 
 
 
 
 
 
Committee Members: 
Advisor- Thomas E. Johnson, Ph.D., Department of Integrative Physiology 
Jim Cypser, Ph.D., Department of Integrative Physiology 
David E. Sherwood, Ph.D., Department of Integrative Physiology 
Diane Martichuski, Ph.D., Department of Psychology and Neuroscience 
 
 
March 31, 2013 
Assessing Healthspan in Long Lived C. elegans 
1 
 
Abstract 
  
 “The plasticity of ageing suggests that longevity may be controlled epigenetically by specific 
alterations in chromatin state” (Greer and Brunet, 2010). Epigenetics, in a broad sense, is a bridge 
between genotype and phenotype—a phenomenon that changes the final effect of a locus or 
chromosome without changing the underlying DNA sequence. This project reviews research performed 
by Greer and Brunet, (2010), Hamilton et al., (2013), and Lee et al., (2008), that involved the use of RNAi 
to modify an epigenetic effect on the lifespan of the soil nematode C. elegans. RNA interference (RNAi) 
was used to regulate lifespan in C. elegans by causing deficiencies in methylation of histone H3 at lysine 
4 (H3K4). While the previously mentioned authors observed extended lifespan in C. elegans treated with 
RNAi, neither study considered the quality of health of the animals with extended lifespan. Herein, 
methods used in previous studies were replicated to produce long-lived C. elegans, but the focus was 
quantifying the healthspan of the animals. Healthspan is a novel term in research that describes the 
length of a healthy life. When considering lifespan-extending treatments we must consider 
“healthspan”- the healthy adult period of unimpaired life that precedes functional decline (Herndon et 
al., 2002).  A key question is whether the increasing proportion of the population surviving to advanced 
ages will display continued quality of existence, which can be defined as delayed onset of chronic illness 
and physical/mental decline. Experimental animals were classified into four categories that reflect 
health based on frequency of movement. Upon analysis of the data, it appears that mutations for genes 
wdr-5.1 and set-4, and RNAi-mediated knock down of set-2 produced an improved heatlhspan:lifespan 
ratio.  However RNAi-mediated knock down of genes wdr-5.1, set-9, set-15, and set-18 did not improve 
the healthspan:lifespan ratio.  
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Introduction 
 
 Throughout history, humanity has been interested in the concept of “the fountain of youth”. If a 
lifetime is limited, is it possible to prolong our period of life on Earth? Ageing research and medical 
treatment have sought to find means to extend lifespan, but at what point does physical decline 
significantly reduce the quality of life? While recent exciting discoveries have been made about the 
connection of genetics and the ageing process, it is unknown if advances in life extension technology are 
also accompanied by an increase in the extension of an organism’s health and well-being. 
 
Definition of Healthspan 
Healthspan is a term that describes the length of a healthy life. When considering lifespan-
extending treatments we must consider “healthspan”- the healthy adult period of unimpaired life that 
precedes functional decline (Herndon et al., 2002). Healthspan is a new focus in ageing research. While 
it is interesting to investigate methods of life extension, it is important to consider the quality of 
prolonged life. A key question is whether the increasing proportion of the population surviving to 
advanced ages will display continued quality of existence, which can be defined as delayed onset of 
chronic illness and physical/mental decline. An organism may possess longevity, but if it is frail and ill for 
a large portion of its late life, then perhaps life-extension is not a desirable pursuit. Ideally organisms 
that have an extended lifespan also have an extended healthspan. Research on life extension should aim 
to increase lifespan while decreasing time spent in a state of morbidity. There are several possible 
relationships between healthspan and lifesapn. 
 
  
Figure 1: Concept adapted from (Kitzenberg, 2012). The bar represents lifespan with the black portion 
representing the duration of morbidity. 
 
Possible Healthspan:Lifespan Relationship Scenarios 
 
Present morbidity 
 
1) Life extension without healthspan extension 
 
2) Life extension with no change in morbidity (postponed morbidity) 
 
3) Compression of Morbidity 
 
4) Compression of morbidity with life extension 
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Figure 1 illustrates that when compared to present trends in morbidity, scenario 2) life 
extension with no change in morbidity, and scenario 4) life extension with compression of morbidity, are 
desirable outcomes for an extended lifespan with an improved healthspan: lifespan ratio. While lifespan 
was not extended in scenario 3) compression of morbidity, the healthspan:lifespan ratio was still 
improved. Organisms that demonstrate a delayed or shortened period of morbidity experience an 
improved healthspan. Obviously the most favorable outcome is to extend lifespan and decrease the 
time an organism spends in morbidity. Scenario 1), life extension with no healthspan extension is not a 
desirable outcome because the organism spends a larger portion of its life in a weakened state. 
 
While the state of knowledge surrounding the connection between genetics and life-extension is 
expanding, little is known about the effects of a prolonged lifespan on healthspan. There has been 
hundreds of genome screenings performed to identify genes associated with ageing.  An analysis of the 
results from three such research studies provided the background knowledge and methodology for this 
project (Greer and Brunet, (2010), Hamilton et al., (2013), and Lee et al., (2008)).Of the three studies, all 
identified genes that are shown to extend lifespan, but none considered healthspan. 
 
 
List of Genes being investigated 
 
Strain Name Gene Study Known phenotypes (other than life-
extension) 
RB1304 wdr-5.1 Greer and Brunet (2010) None. 
RB1025 set- 2 Greer and Brunet (2010) plays a role in germline development, 
postembryonic development, and RNA 
interference 
MT14911 set- 4 Greer and Brunet (2010) Lethal for allele tm1835;  this phenotype was 
not found in three other RNAi screens, and is 
not observed for the probable null allele set-
4(n4600) 
MT16426 set-9 Greer and Brunet (2010) Neither set-9(n4949) nor set-9(RNAi) has any 
obvious phenotypes. 
RB2406 set- 15 Greer and Brunet (2010) None 
VC767 set-18 Greer and Brunet (2010) Neither set-18(gk334) nor set-18(RNAi) has 
any obvious phenotypes. 
RB777 hcf- 1 Hamilton et al. (2013) 
and Lee et al. (2008) 
Negative regulator of adult lifespan. No other 
phenotypes are known. 
 
Table 1: The table represents which studies investigated which genetic modifications of C. elegans 
chosen for this experiment.  
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 Again, strains were selected because they were shown to produce long-lived animals in studies 
performed by Greer and Brunet, (2010), Hamilton et al., (2013), and Lee et al., (2008). Each strain 
represents a mutation in a particular genetic locus that increases lifespan. The right column of the chart 
includes information about other phenotypes besides longevity that are produced by the mutation. 
Strains RB1304 and MT14851 were obtained from The Caenorhabditis Genetics Center, in Minneapolis 
Minnesota. These strains represent C. elegans that are homozygous for the indicated mutant alleles. The 
remaining strains, RB1025, MT16426, RB2406, VC767, RB777, and an additional RB1304 represent genes 
that require the application of RNA interference (RNAi) to produce the long-lived phenotype, and were 
obtained from the Ahringer Library  composed by Julie Ahringer's group at the Wellcome CRC Institute, 
University of Cambridge, Cambridge, UK.  
 
 
Research Question 
Certain genetic mutations that have been proven to extend lifespan in Caenorhabditis elegans 
may or may not also extend healthspan. The objective of this project is to test a set of seven genes 
(table 1) that have a known life-extending effect on the nematode, C. elegans, to assess if they also 
extend the healthspan of the animals. If genetically altered C. elegans display extended lifespan in 
combination with a proportionally extended healthspan, then the genetic treatment may be considered 
favorable.  
 
 
C. elegans as an Animal Model 
Several characteristics make C. elegans an excellent model in genetic research. C. elegans is a 
eukaryote, which carry many homologous genes to those of humans. It is estimated that about 60-80% 
of C. elegans genes have human homologs (Kaletta and Hengartner, 2006). Although C. elegans is a 
small, relatively simple organism it possess many tissue types in common with humans such as muscle, 
intestinal, and neural tissue. Because C. elegans has similar tissue types, it is possible to translate some 
findings from nematode research to higher organisms like humans.  
 The entire C. elegans genome has been sequenced. This feat was possible due to the relatively 
small size of the C. elegans genome which is about 9.7x107   base pairs compared to the human genome 
which is about 3 billion base pairs (Kaletta and Hengartner, 2006). Furthermore, manipulation of the 
genome can be easily accomplished by adding, removing, or altering specific genes through routine 
molecular genetic procedures. 
Apart from its physiological similarity, C. elegans serve as a good animal model because it is easy 
to maintain in a laboratory. Hundreds of nematodes can be kept alive on a small plate of agar. It feeds 
on bacteria which is also easily stored and maintained. The average lifespan of C. elegans is 2-4 weeks, 
so it can be used for modeling the action of certain genes, environments, or treatments over multiple 
generations. 
Another advantage of using C. elegans in genetic research is that the majority of any given 
population of worms are hermaphroditic. Because the worms self-fertilize, once homozygosity has been 
established for a certain gene, there is no change in the genetic make-up between individuals or 
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between generations unless a deliberate or natural mutation occurs. Because the worms are essentially 
identical clones, variations in behavior are minimized, making them very valuable in comparative genetic 
research.  
 A final reason why C. elegans is a particularly good candidate for RNAi research is that it is one 
of few organisms that display the phenomenon of “spreading”. Thus far, C. elegans is one of few 
eukaryotic species known to produce a systemic response to the localized introduction of dsRNA 
(Descotte, 2003.) Although dsRNA may be introduced to only a few cells in the animal, the subsequent 
silencing effect occurs throughout the majority of the organism’s cells. “Spreading” phenomenon is ideal 
because it demonstrates the effects of RNAi on a systemic level versus a localized one. 
 
 
 
Fig. 2: Anatomy of Caenorhabditis elegans 
http://avery.rutgers.edu/WSSP/StudentScholars/project/introduction/worms.html 
 
Induction of Gene Knock Down through RNA interference 
The majority of nematodes used in this project were fed E.coli bacteria containing a plasmid 
with an antisense RNA fragment to induce RNA interference (RNAi). When exogenous double stranded 
RNA molecules are introduced into a cell, a molecular response is generated to suppress expression of 
the gene with a nucleotide sequence complementary to the foreign RNA (Kammath et al., 2000). RNAi 
knocks down gene expression in two ways; by post-transcriptionally blocking protein production via 
mRNA, or through the modification of histone methylation at the transcriptional level in the genome. 
This project focuses on the actions of small interfering RNAi (siRNA) to initiate histone methylation to 
produce the desired life-extending result. Transcriptional RNAi silencing is initiated when dsRNA is 
cleaved in the cytoplasm by the ribonuclease like enzyme Dicer to generate small interfering RNA 
molecules that are about 22 nucleotides long (Bagasral et al., 2004). These small interfering RNAs 
(siRNAs) load onto an effector complex called RITS (RNA-induced transcriptional silencing complex) that 
contains an argonaute protein and targets complementary mRNAs associated with heterochromatin for 
inactivation (Verdel et al., 2004).  RITS uses siRNA- dependent base pairing to guide association with 
either DNA or nascent RNA sequences at the target locus destined to be silenced, an association that is 
stabilized by direct binding to a methylated histone. RITS triggers heterochromatin formation in concert 
with well-known heterochromatin associated factors and directly links RNA silencing to heterochromatin 
modification (Allis et al., 2007).  
The maintenance of heterochromatin regions by the RITS complex has been described as a self-
reinforcing feedback loop, in which the RITS complex binds the methylated histones of a 
heterochromatin region and induces co-transcriptional degradation of any emerging messenger 
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RNA (mRNA) transcripts. The degraded mRNA fragments are then used as substrates in RNA-dependent 
RNA polymerase  to replenish the complement of siRNA molecules (Sugiyama et al., 2005).  
 
 
Figure 3: An example of the process of heterochromatin 
modification via RITS complex. (Verdel, 2004). In this project, 
histone residue  H3K4 was studied. 
 
 
 
Manipulation of Chromatin Modifiers Produces Effect 
Histones are proteins found in the nuclei of 
eukaryotic cells that function to package long strands of DNA 
into structural units called nucleosomes (Allis et al., 2007).  It 
is important to note that in C. elegans, direct DNA 
methylation does not occur and epigenetic modification 
must be accomplished via histone modification (Simpson et al., 1984). The assembly of nucleosomes 
creates chromatin which is the material from which chromosomes are composed. There are five specific 
families of histones, H1, H2(A), H2(B), H3, H4, and H5. Histones H2(A),H3(B), and H4 are known as core 
histones. H2A and H2B or H3 and H4 assemble to create a nucleosome core particle on which 147 base 
pairs of DNA  wrap around (Luger et al., 1997). H1 and H5 histones act as linker proteins to bind the 
nucleosome at entry and exit sites and secure DNA in place on the core histone particle (Farkas, 2006).  
 
Because histones are directly involved in the organization and packaging of DNA within the 
nucleus, modification of parts of a histone through acetylation, phosphorylation, and methylation can 
cause changes in regulation of gene function. Acetylation is correlated with an “open”  chromatin 
configuration, and therefore with regions of DNA that are exposed and poised for transcription (Allis et 
al., 2007). Acetylation acts to neutralize the positive charge of a specific lysine site and reduce the 
binding strength of strongly basic histones or histone tails to negatively charged DNA.  Although the 
mechanisms behind histone phosphorylation are not as well understood, histone phosphorylation 
similarly modifies chromatin to become transcriptionally active (Mahadevan et al., 1991). Methylation is 
unique because it can occur on both lysine and arginine, and can have positive or negative affect on 
transcriptional expression depending on the position of the residue (Allis et al., 2007). Also, there are 
three possible methylated states for each lysine residue, i.e. lysine can be mono-, di-, or trimethylated. 
Of particular interest, trimethylation of the histone H3 at lysine 4 (H3K4) is linked to activation of 
transcription (Allis et al., 2007). RNAi-mediated knock down of the SET domain of methyltransferases, 
and other genes directing histone methylation, has been shown to modify H3K4 and regulate healthspan 
in C.elegans (Greer and Brunet, 2010). Greer and Brunet found that excess H3K4 trimethylation is 
detrimental to lifespan. 
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Because histone proteins are among the most highly conserved proteins in eukaryotes, histones play a 
crucial role in the biology of the nucleus in many organisms. Studying histone modification in C. elegans 
is useful because results would likely translate across species to human histone regulation.  
 
Hierarchy of chromosome composition: DNAhistonechromatinnucleosomechromosome 
 
 
List of Genes Being Investigated and Effect on Histone  Modification of Chromatin 
 
Strain Name Suppressed Gene Function on modification of chromatin 
RB1304 wdr-5.1 Histone trimethylation of H3K4 
MT14911 set-2 Methyltransferase. Histone 
trimethylation/ methyltransferase of 
H3K4 
RB1025 set-4 Methyltransferase. Histone 
trimethylation of H3K4 
MT16426 set- 9 Methyltransferase. Histone 
methylation of H3K4 
RB2406 set-15 Methyltransferase. Histone 
methylation of H3K4 
C767 set-18 Methyltransferase. Histone 
methylation of H3K4 
RB777 hcf-1  Binds to daf-16 and prevents 
transcription. Histone trimethylation 
of H3K4 
Table 2: Knock down of these genes modulates methylation of histone 3 at lysine 4 (H3K4). Decreased 
methylation is associated with an altered chromatin state and a slowing of the ageing process.  
 
Although all the genes being investigated function in histone modification, there are unique mechanisms 
by which each contributes to methylation or cell development. RNAi-mediated knock down of gene wdr- 
5.1 decreases histone methylation, increases transcription, and extends lifespan (Greer and Brunet, 
2010). Knockdown of set-2, set-4, set-9, set-15, and set-18 disables methyltransferase mechanisms 
(Greer and Brunet, 2010). Knockdown of hcf-1 increases expression of daf-16. Hcf-1 forms a complex 
with daf-16 in the nucleus by binding to various transcription and chromatin factors. Physical association 
of hcf-1 and daf-16 reduces the expression of daf-16. Daf-16 is an effector of the insulin-like growth 
factor pathway which functions to regulate lifespan through development, metabolism, and stress 
response (Lee et al., 2008) and (Hamilton et al., 2013). Hcf-1 has also been shown to recruit 
methyltransferase set-1 (Narayanan et al., 2007). 
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Methods 
 
Standard Conditions for Nematode Growth 
To ensure standard conditions for all experiments, C. elegans were kept on a 6 cm diameter 
plate of nematode growth medium (NGM) agar stored at a constant temperature of 20⁰ C. Mutant 
worms were fed Escherichia coli strain OP50 plated at a concentration of 1x109  cells/ml. In RNAi 
experiments, E. coli strain HT 115 containing the appropriate vector expressing dsRNA of the genes of 
interest is used in place of OP50 (Greer and Brunet, 2010). RNAi plates were spotted with ampicillin (100 
micro grams/ml working concentration) and isopropylthiogalactoside (IPTG 1 mM working 
concentration) to prevent contamination and encourage RNA polymeration. 
 
Gene Sequencing 
Before application in the experiment, the sequence of each RNAi strain was confirmed through 
genome sequencing performed by a company called ACGT in Wheeling, IL. A technique called direct 
colony sequencing was used where bacterial colonies containing the RNAi-producing plasmid were 
amplified, and then the DNA plasmid was extracted and sequenced. This step ensured that the gene of 
interest was present in the plasmid contained in the cells of the culture obtained from the Ahringer 
library. 
 
Determining Age 
It was crucial to this experiment to obtain data from worms that were the same age. To acquire 
an age-synchronous population, adult worms for each strain were placed on a plate spotted with OP50. 
After eggs were apparent on the plate, the population was treated with a hypochlorite solution 
composed of 7ml saline solution S. basal, 2 ml Na hypochlorite, and 1 ml 5N KOH for approximately 10 
minutes. This hypochlorite solution killed the adult worms and any larvae but did not affect the eggs. 
The eggs were washed and transferred to fresh plates. All animals hatching from eggs surviving after the 
hypochlorite treatment were age-synchronized and could be used for the experiment. 
 
Observation 
Worms enter adulthood when they begin laying eggs, which begins 3-4 days after hatching. For 
the experiments performed for this project, a worm’s lifespan was recorded starting the first day of 
adulthood. Worms were manually transferred to fresh plates daily using a small platinum wire that 
serves as a worm pick. The pick was sterilized by flame between plates to prevent cross-contamination. 
Worms were scored and transferred daily until they stop laying eggs. After the reproductive stage of life 
was over, worms were scored every day but transferred to a new plate 3 times a week or earlier if 
contamination on the plate was apparent. 
 
Healthspan Classification 
There are many ways to assess the health of an organism. Movement, appearance, and fertility 
are all criteria that can be used to evaluate well-being. In the experiments performed for this project, 
health was measured by observed movement.  Since many organisms become physically slower as they 
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age, measuring movement was an appropriate and non-invasive approach to quantify the ageing 
process. Each day, worms were individually observed for 1 minute before being transferred. After 
observation, they were classified into one of four categories (Herndon et al., 2002). As the worms age, 
they move through the four movement classifications. Healthy worms move spontaneously or if 
provoked. Class C is considered to be the beginning of morbidity. Once a worm has entered class C 
death usually occurs within a couple of days. The classification system is important to this experiment 
because it is a way to quantify the health of C. elegans over the lifespan of the worm. Worms that are 
considered to have a long healthspan spend less time in Class C than worms with a short healthspan. 
 
 
Spontaneous movement. The nematode can be observed moving across the 
plate. Tracks may be present behind the 
nematode. If the nematode is not moving forward, 
it can bend the majority of its body right, left, and 
in an “omega turn”. The nematode performs 
several body bends during the duration of 
observation. 
Provoked Movement The nematode is stationary until prodded with a 
platinum pick. After being provoked, the 
nematode moves forward or backward or begins 
body bends. Tracks may be present behind the 
nematode. 
Class C The nematode is not dead, but is not moving freely 
and barely moves when provoked. When it moves, 
typically only the anterior of the worm is mobile. 
There are no fresh tracks, indicating that the 
nematode has not moved recently. 
Dead The nematode appears limp and lifeless. It does 
not move at all even when prodded with a worm 
pick. 
Table 3: Illustrates movement classifications used to score healthspan in C. elegans. 
 
Data Collection In 3 Experimental Groups 
 Healthspan group A consisted of mutant worms with knockdown of the wdr-5.1 gene and set-4 
gene compared against a wild-type (N2) control. Healthspan group B consisted of wild type worms 
treated with RNAi-mediated knock down of the wdr-5.1 gene, set-9 gene, set-15 gene, and set-18 gene 
compared to wild type worms treated with empty vector (EV). A repeat experiment of Healthspan B was 
performed. Healthspan group C consisted of wild type worms treated with RNAi-mediated knock down 
of the hcf-1 gene, and set-4 gene compared to wild type worms treated with empty vector. A repeat 
experiment of Healthspan C was performed. 
 Due to time constraints, healthspan experiments were organized in three groups and data was 
collected over a course of 6 months. Data from Healthspan Group A was collected between October and 
November. Data from the first experiment of Healthspan Group B was collected between January and 
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February. The repeat experiment was conducted between February and March. Healthspan Group C 
data from the first and repeat experiment were collected simultaneously in March. It is important to 
clarify that genes were placed into each healthspan group at random, and genes in each group have no 
association with each other besides that data was collected in the same time frame. 
Statistical Analysis 
Once data were compiled, two statistical tests were performed to determine if there were 
significant differences in the progression of healthspan between genes being investigated compared to a 
control group. A log rank test was run to assess if there were differences in the amount of time each 
variable spent in each healthspan category compared to other variable. A Cox proportional hazard test 
was conducted to assess how large the effect size was between variables. Statistical analyses of lifespan 
and healthspan were performed on Kaplan-Meier survival curves in the program R (Greer and Brunet, 
2010). Results from the Kaplan-Meier curve reflect the probability that a fraction of the population will 
remain in a state over time. 
 
Results  
Lifespan Analysis 
 Each gene was selected because it had been proven to extend lifespan in previous studies 
performed by Greer and Brunet, (2011), Hamilton et al. (2013), and Lee et al,. (2008). A lifespan assay 
was performed on each group to assess if lifespan extension occurred. Surprisingly, almost the all results 
indicated no significant effect on life extension, or in many cases a significantly shorter lifespan 
compared to the control. There was one exception observed in the set-2 gene which exhibited 
significant life extension compared to the control. 
 In Healthspan group A, experimental groups did not display life extension. In fact, mutant 
worms for wdr-5.1 and set-4 RNAi knock down had significantly shorter lifespans than wild type worms 
(p=0.020922, and p=0.000544) respectively. Results from the Cox proportional hazard tests indicate that 
worms treated with wdr-5.1 RNAi were 2.0 times more likely to die before the control, and worms 
treated with set-4  RNAi were 2.7 times more likely to die before the control worms. 
 In Healthspan group B, experimental groups did not display life extension. Worms treated with 
wdr-5.1, set-9, and set-18 RNAi were significantly less long-lived than wild type worms treated with 
empty vector (p= 0.0321, p=0.0154, and p=0.0587) respectively. Worms treated with set-18 RNAi 
showed no significant difference in lifespan compared to worms treated with empty vector. Results 
from the Cox proportional hazard tests indicate that worms treated with wdr-5.1, set-9, and set-15 RNAi 
were 1.7, 1.8 and 1.6 times more likely to die before the control worms respectively. Interestingly, the 
repeat experiment of Healthspan group B provided data that did not indicate a significant difference in 
lifespan between any of the RNAi variables and the control group.  
 In Healthspan group C, worms treated with hcf-1 RNAi had significantly shorter lifespans than 
wild type worms treated with empty vector (p=0.001737). However, worms treated with set-2 RNAi 
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displayed significantly longer lifespans than wild type worms treated with empty vector (p=0.000271). 
Results from the Cox proportional hazard test indicate that worms treated with hcf-1 RNAi were 2.6 
times more likely to die before the control, while worms treated with set-2 RNAi were 1.7 times more 
likely to die after the control worms. In the repeat experiment, worms treated with hcf-1 RNAi showed 
no significant difference in lifespan compared to wild type worms treated with empty vector. Worms 
treated with set-2 RNAi again displayed significantly longer lifespans than wild type worms treated with 
empty vector (p=4.47e-5). Results from the Cox proportional hazard test indicated that worms treated 
with set-2 RNAi in the repeat experiment were 1.7 times more likely to die after the control worms. 
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Healthspan Analysis 
 Although many of the gens in this experiment did not display the expected phenotype of life 
extension compared to the control, data collected from scoring healthspan were still considered. 
Experimental Healthspan Group A  (wdr- 5.1 and set-4 mutants compared to N2) 
 In Healthspan group A, worms treated with  wdr-5.1 and set-4  RNAi maintained spontaneous 
movement for significantly less time compared to worms treated with empty vector (p=0.0198 and 
p=2.83e-11, respectively). Results from the Cox proportional hazard test indicated that worms treated 
with wdr-5.1 and set-4 RNAi were 1.2 and 1.6 times more likely to lose spontaneous movement before 
the control worms respectively. Worms treated with wdr-5.1 and set-4  RNAi maintained provoked 
movement for significantly less time compared to worms treated with empty vector (p=0.00432 and 
p=1.26e-6,respectively). Results from the Cox proportional hazard test indicated that worms treated with 
wdr-5.1 and set-4 RNAi were 1.3 and 1.6 times more likely to lose provoked movement before the 
control worms respectively. Worms treated with wdr-5.1 and set- 4 RNAi maintained the stage-C 
phenotype before death for significantly less time compared to worms treated with empty vector 
(p=0.000208 and p=0.011252, respectively). Results from the Cox proportional hazard test indicated that 
worms treated with wdr-5.1 and set-4 RNAi were 2.3 and 1.7 times more likely to lose spontaneous 
movement before the control worms, respectively. 
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Experimental Healthspan Group B (wdr-5.1, set-9. set-15, and set-18 RNAi compared to EV) 
 In Healthspan B, worms treated with wdr-5.1, set-9, set-15, and set-18  RNAi maintained 
spontaneous movement for significantly less time compared to worms treated with empty vector 
(p=5.53e-8, p=2.63e-4, p=1.36e-10, and p=3.26e-8, respectively).  Results from the Cox proportional hazard 
test indicated that worms treated with wdr-5.1, set-9, set-15, and set-18  RNAi were 1.4, 1.6, 1.5, and 1.4 
times more likely to lose spontaneous movement before the control worms, respectively. In the repeat 
experiment, worms treated with wdr-5.1 and set-9 RNAi displayed no significant difference in the loss of 
spontaneous movement over time compared to worms treated with empty vector (p=0.54487 and 
p=0.21672, respectively). Worms treated with set-15, and set-18  RNAi maintained spontaneous 
movement for significantly less time compared to worms treated with empty vector (p=0.00123 and 
p=1.08e-5, respectively).  Results from the Cox proportional hazard test indicated that worms treated with 
set-15, and set-18 RNAi were 1.2 and 1.3 times more likely to lose spontaneous movement before the 
control worms, respectively. 
 Worms treated with wdr-5.1, set-9, set-15, and set-18  RNAi maintained provoked  movement 
for significantly less time compared to worms treated with empty vector (p=0.000342, p=0.001842, 
p=0.000503, and p=0.048613, respectively). Results from the Cox proportional hazard test indicated that 
worms treated with wdr-5.1, set-9, set-15, and set-18  RNAi were 3.2, 2.9, 2.9, and 1.9 times more likely 
to lose provoked movement before the control worms, respectively. In the repeat experiment, worms 
treated with wdr-5.1, set-9, and set-18  RNAi maintained provoked movement for significantly less time 
compared to worms treated with empty vector (p=0.01077, p=0.024444, and p=0.00191, respectively). 
Results from the Cox proportional hazard test indicated that worms treated with wdr-5.1, set-9, and set-
18 RNAi  were 2.5, 2.0, and 2.7 times more likely to lose provoked movement before the control worms, 
respectively.  Worms treated with set-15  RNAi displayed no significant difference in the loss of 
provoked movement over time compared to worms treated with empty vector (p=0.80479).  
 Worms treated with wdr-5.1 and set-9 RNAi maintained the stage-C phenotype before death for 
significantly less time compared to worms treated with empty vector (p=0.03082 and p=0.00502, 
respectively). Results from the Cox proportional hazard test indicated that worms treated with wdr-5.1 
and set-9 RNAi were 1.8 and 2.1 times more likely to lose stage-C phenotype before the control worms, 
respectively.Worms treated with set-15 and set-18 RNAi displayed no significant difference in the loss of 
the stage-C phenotype before death compared to worms treated with empty vector (p=0.08128 and 
p=0.11276, respectively)y.  The repeat experiment of Healthspan group B provided data that did not 
indicate a significant difference in display of stage-C phenotype between any of the RNAi variables and 
the control group. When compared to the control, the p-value for worms treated with wdr-5.1 RNAi was 
(p=0.5878, p=0.0869, p= 0.9303, and p= 0.0774) respectively. 
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Experimental Healthspan Group C (hcf-1 and set-2 RNAi compared to EV) 
 In Healthspan group C, worms treated with hcf-1  RNAi maintained spontaneous movement for 
significantly less time compared to worms treated with empty vector (p=1.268e-5) and were 1.3 times 
more likely to lose spontaneous movement then the control. Worms treated with set-2  RNAi displayed 
no significant difference in loss of spontaneous movement over time compared to worms treated with 
empty vector (p=0.5000).  In the repeat experiment, worms treated with hcf-1  RNAi displayed no 
significant difference in loss of spontaneous movement over time compared to the worms treated with 
empty vector (p=0.37941). Worms treated with set-2  RNAi maintained spontaneous movement for a 
significantly longer period of time time compared to worms treated with empty vector (p=0.00246). 
Results from the Cox proportional hazard test indicated that set-2 knockdown worms were 1.21 times 
more likely to maintain spontaneous movement compared to the control worms, respectively.   
  Worms treated with hcf-1  RNAi maintained provoked movement for significantly less time 
compared to worms treated with empty vector (p=4.81e-5), and were 9.0 times more likely to lose 
provoked movement than the control. Worms treated with set-2  RNAi displayed no significant 
difference in loss of provoked movement over time compared to worms treated with empty vector 
(p=0.0692). In the repeat experiment, similar results were observed. Worms treated with hcf-1  RNAi 
maintained provoked movement for significantly less time compared to worms treated with empty 
vector (p=0.044), and were 2.0 times more likely to lose provoked movement compared to the control. 
Worms treated with set-2  RNAi displayed no significant difference in loss of provoked movement over 
time compared to worms treated with empty vector (p=0.341).  
 Worms treated with hcf-1  RNAi maintained the stage-c phenotype before death for significantly 
less time compared to worms treated with empty vector (p=0.00538) and were 3.3 times more likely to 
lose the stage-C phenotype than the control. Worms treated with set-2  RNAi displayed no significant 
difference in loss of stage-C phenotype before death over- time compared to worms treated with empty 
vector (p=0.15906). However, in the repeat experiment, worms treated with hcf-1  RNAi displayed no 
significant difference in loss of stage-C phenotype before death over- time compared to worms treated 
with empty vector (p=0.853). Worms treated with set-2  RNAi also displayed no significant difference in 
loss of stage-C phenotype before death over- time compared to worms treated with empty 
vector(p=0.650).  
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Summary of Results 
Gene (and source 
of knockdown) 
Life-span 
compared to 
control 
Loss of 
spontaneous 
movement 
compared to 
control 
Loss of provoked 
movement 
compared to 
control 
Loss of stage-C 
phenotype 
compared to 
control 
Wdr-5.1 (mutant) Shorter p=0.020922 
Coef= 2.0 
Likely before 
P=0.0198 
Coef=1.2 
Likely before 
P=0.00432 
Coef=1.3 
Likely before 
P=0.000208 
Coef=2.3 
Set-4 (mutant) Shorter p=0.000544 
Coef=2.8 
Likely before 
P=2.83e
-11 
Coef=1.6 
Likely before 
P=1.26e-
6 
Coef=1.6 
Likely before 
P=0.011252 
Coef=1.7 
Wdr-5.1 (RNAi) Shorter or not 
different 
p=0.0321 
p=0.5878 
Coef=1.7 
Likely before or no 
difference 
P=5.53e
-8
 
Coef=1.4 
P=0.54487 
Likely before 
P=0.000342 
Coef=3.2 
P=0.01077 
Coef=2.5 
 
Likely before or no 
difference 
P=0.03082 
Coef=1.8 
P=0.05878 
Set-9 (RNAi) Shorter or not 
different 
p=0.0154 
p=0.2384 
Coef=1.8 
Likely before or no 
difference 
p=2.63e
-4
 
coef=1.6 
p=0.21672 
Likely before 
P=0.001842 
Coef=2.9 
P=0.02444 
Coef=2.0 
Likely before or no 
difference 
P=0.00502 
Coef=2.1 
P=0.0869 
Set-15 (RNAi) Shorter or not 
different 
p=0.0587 
p=0.0836 
Coef=1.6 
Likely before 
P=1.36e
-10
 
Coef=1.5 
P=0.00123 
Coef=1.2 
Likely before or no 
difference  
P=0.000503 
Coef=2.9 
P=0.80479 
No difference 
P=0.08128 
P=0.9303 
Set-18 (RNAi) Not different 
P=0.126 
P=0.9266 
Likely before 
P=3.26e
-8 
Coef=1.4 
p=1.08e-
5 
Coef=1.3 
Likely before 
P=0.048613 
Coef=1.9 
P=0.00191 
Coef=2.7 
No difference 
P=0.11276 
P=0.0774 
Hcf-1 (RNAi) Shorter or not 
different 
p=0.001737 
P= 0.325 
Coef=2.6 
Likely before or no 
difference 
P=2.68e-
5 
Coef=1.3 
P=0.37941 
Likely before 
P=4.81e-5 
Coef= 9.0 
P= 0.0444 
Coef= 2.0 
Likely before or no 
difference 
P=0.00538 
Coef=3.3 
P=0.853 
Set-2 (RNAi) Longer  
p= 0.00027 
Coef=1.65 
p= 4.73e-
5
 
Coef=1.70 
Likely after or no 
difference 
P=0.5 
P= 0.00246 
Coef= 1.21 
No difference 
P=0.0692 
P=0.341 
No difference 
P=0.15906 
P=0.650 
 
Table 4: Listed p-values for original experiments and repeat testing. Values for original experiment are 
listed first, and repeat tests second. Coef= exponential coefficient from proportional hazards test. Value 
represents the likelihood of event  represented by transition from one healthspan classification to the 
next. If p-values were insignificant, the exponential coefficient was not included. 
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Discussion 
Speculation On Why Life Extension Did Not Occur 
 Most of the results obtained from the lifespan assay did not match the expectation based on 
observed life extension in studies performed by Greer and Brunet, (2010), Hamilton et al., (2013), and 
Lee et al., (2008).  The only exception was life extension displayed in both the original experiment and 
the repeat testing of RNAi knock down of the set-2 gene. There are several explanations that may 
account for the absence of life extension in all gene knockdown variables apart from set-2. First, 
although every effort was made to ensure that methods were identical to those cited by Greer and 
Brunet, (2010), it is possible that there was an overlooked difference in agar plates the worms were kept 
on, transfer technique or frequency of transfer of worms, technique for achieving an age synchronous 
population, or any other number of variables that may have contributed to the absence of effect. 
Another possible explanation for the absence of life-extension is ambiguity regarding the wild-type C. 
elegans used for RNAi treatment and as a control. It is assumed that wild-type worms used in different 
laboratories are almost genetically identical, however sometimes mutations occur and produce different 
strains of wild-type worms. The wild-type used in this project were N2, but other strains include RRF3 
and ER11. It is possible that the wild-type strain used by any of the studies preceding this project were 
dissimilar from N2 and the difference was responsible for incompatible results.   Finally, in the 2010 
Greer and Brunet study, wdr-5.1 and set-4 mutants were backcrossed to ensure that they were 
heterozygous at the loci of the mutation of interest. Wdr-5.1 and set-4 mutants were not back crossed 
in this experiment and were homozygous, and this difference may have caused the significantly shorter 
lifespan compared to the control. 
 While unlikely, since three major studies support the life-extending effects of each gene 
investigated, it is necessary to note that a possible reason why no life extension occurred is because 
knockdown of the genes in question does not produce a prolonged lifespan. 
Interpretation of Results  
Healthspan Group A 
Present morbidity 
 
3) Compression of Morbidity 
 
 
 Healthspan group A worms were homozygous mutants for wdr-5.1 and set-4 alleles. Both Wdr-
5.1 and set-4 mutants lost spontaneous and provoked movement in significantly fewer days on average 
compared to the wild-type worms. Since spontaneous and provoked movement are indicative of a 
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healthy state, loss of these phenotypes early on suggests poor healthspan. Wdr-5.1 and set-4 mutants 
entered and left the stage-C phenotype significantly sooner on average than the wild-type worms. The 
wdr-5.1 and set-4 mutants died in fewer days than the control worms, but also maintained stage-C 
phenotype for fewer days on average than the control worms. Because the stage-C phenotype 
represents the start of morbidity, the amount of time which the wdr-5.1 and set-4 mutants entered and 
remained in stage-C indicates that they display a compression of morbidity from table 1. 
Healthspan Group B 
Present morbidity 
Presen 
No life-extension or improved healthspan: lifespan ratio 
 
 
 Overall, worms from Healthspan group B displayed either significantly fewer days, or no 
significant difference  in days spent in a healthy state of spontaneous or provoked movement. There 
was no significant difference in the time spent in a state of morbidity represented by the stage-C 
phenotype in both experimental groups. For all of the worms in Healthspan group B, lifespan was 
shorter with no effect on the healthspan:lifespan ratio. 
Healthspan group C 
Present morbidity 
 
2) Life extension with no change in morbidity (postponed morbidity) 
 
 
 . There was no significant difference between any of the healthspan classification categories 
demonstrated in both experiments by hcf-1 knockdown. However, set-2 maintained spontaneous 
movement and was  significantly longer lived compared to the control worms. Therefore, knock down of 
set-2 produces worms that display a shift to the right in the healthspan:lifespan ratio represented in 
Figure 1. 
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Conclusion 
 Worms treated with RNAi that mediates the knock down of the set-2 gene demonstrated 
extended lifespan as observed in research conducted by Greer and Brunet. The healthspan:lifespan ratio 
in these animals was improved because the start of the state of morbidity shifted to the right in 
proportion to the extension of lifespan. 
 It is difficult to assess the healthspan of the other genes investigated in this project because 
none displayed the expected phenotype of life extension observed in studies performed by Greer and 
Brunet. If healthspan is considered disregarding lifespan, then it can be concluded that mutants for 
genes wdr-5.1 and set-4 expressed compression of morbidity while worms treated with RNAi that 
mediates the knockdown of wdr-5.1, set-9, set-15, and set-18 expressed a shorter lifespan, without any 
change or improvement in healthspan:lifespan ratio.  
 
Limitations and Moving Forward with Healthspan  
 A major limitation encountered in this study was the unexpected absence of a life extension 
observed in the subjects. Because the research question was based on the assumption that life 
extension would occur, it is difficult to clearly conclude what the true relationship of the 
healthspan:lifespan ratio is for each gene of interest. Another major limitation was time constraints. 
Ideally, more repeat experiments would be performed to further validate or invalidate findings. For 
example, there was no repeat experiment performed for Healthspan Group A, and therefore results 
collected from the data from that group cannot be considered with as much confidence as results from 
the other healthspan groups. Time constraints were additionally limiting because it was not possible to 
collect data from each gene of interest within the same time frame. Because it can take up to several 
hours to score and transfer worms, it was essential, although not ideal, to investigate certain genes at 
different times instead of all at once. Error that might have occurred from collecting data over different 
time frames could be avoided if all the gene variables could be investigated at once. A final limitation of 
this study was sample size. Sample sizes ranged from 30-60 before subjects were even censored from 
the experiment. An increase in sample size would provide more accurate results. As ageing research and 
technology continues to advance, the relevance and importance of the healthspan concept will also 
expand. The lifespan scenarios discussed in this project are crucial to understanding the complexity of 
the interaction of healthspan and lifespan. 
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